Blog Archives - Page 813 of 1183 - Shapiro, Washburn & Sharp

FDA Panel Recommends Halt in Use of Drug to Treat Breast Cancer

A panel of advisers to the U.S. Food and Drug Administration has recommended halting the use of Avastin (bevacizumab from Genentech) for treating breast cancer, pointing to studies showing the medication was not effective for that purpose, the Bellingham Herald reported. The recommendation followed two days of sometimes emotional testimony from doctors, patients and advocacy…

read more